Quote from Trump in article mentions HCL.
Dr Yo, 45 minutes ago:
“3 different shareholder groups think it’s their drug that DJT will announce.
All 3 in stage 3 trials and all 3 very strong candidates”
Leronimab
Lenzilumab
Aviptadil
My money is on Aviptadil aka RLF-100